🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 1/2, open-label, multicenter study to determine the efficac...
Status
Active Not Recruiting
Location
Local Institution - 0006
Start Date
2017-11-27
Trial ID
NCT03331198
This phase II trial tests whether mosunetuzumab and/or polatuzumab vedotin ...
Status
Recruiting
Location
Banner University Medical Center - Tucson
Start Date
2023-06-12
Trial ID
NCT05633615
The purpose of this study is to evaluate the safety and efficacy of lisocab...
Status
Recruiting
Location
University Of Colorado
Start Date
2025-11-06
Trial ID
NCT07015242
This phase II trial studies how well the addition of nemtabrutinib to lisoc...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2026-09-01
Trial ID
NCT07194980
Treatments Being Tested
This phase II trial tests how well adding lisocabtagene maraleucel (liso-ce...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2023-06-02
Trial ID
NCT05672173
This open-label Phase 1 study will evaluate the safety, PK, and antitumor a...
Status
Completed
Location
Local Institution - 0006
Start Date
2016-01-06
Trial ID
NCT02631044
The purpose of this study is to compare the efficacy and safety of liso-cel...
Status
Withdrawn
Location
Banner MD Anderson Cancer Center
Start Date
2024-01-16
Trial ID
NCT06205290
Treatments Being Tested
The study will be conducted in compliance with the International Council fo...
Status
Completed
Location
Local Institution - 129
Start Date
2018-10-23
Trial ID
NCT03575351
Treatments Being Tested
This is a Phase 2, open-label, multicenter study to determine the efficacy ...
Status
Completed
Location
Banner MD Anderson Cancer Center
Start Date
2018-07-27
Trial ID
NCT03483103
Treatments Being Tested
This is an expanded access protocol that will be conducted at sites qualifi...
Status
Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT04400591
Treatments Being Tested